Understanding heart rhythm disorders in patients on ECMO for severe heart failure
Official title: Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by Extra Corporeal Membrane Oxygenation Veno-arterial (ECMO VA) for Refractory Cardiogenic Shock
Run by Assistance Publique - Hôpitaux de Paris · NCT05788120 · Data updated 2026-11-12
This study looks at how often heart rhythm problems, like atrial fibrillation, happen in patients on a special heart support machine for severe heart failure and what those problems mean for their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 20 sites (Angers and 19 other locations) |
| Status | Recruiting |
| Started | April 28, 2023 |
| Main results expected | April 28, 2028 |
| Study ends | April 28, 2028 |
| Registry record updated | April 17, 2026 |
| Trial ID | NCT05788120 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 18 years or older who are receiving VA ECMO for refractory cardiogenic shock.
✕Probably not a fit
Patients who are under legal protection or those receiving VA ECMO for refractory cardiac arrest may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the occurrence and outcomes of cardiac rhythm disorders, particularly atrial fibrillation, in patients receiving veno-arterial extracorporeal membrane oxygenation (VA ECMO) for refractory cardiogenic shock. Data will be collected from intensive care units, focusing on both short-term and long-term prognosis of these arrhythmias. The study will utilize 12-lead electrocardiograms to document episodes of atrial fibrillation and will follow up with patients via phone calls to assess their vital status after one year. The findings will help clarify the incidence and complications associated with rhythm disorders in this critical patient population.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for cardiac rhythm disorders in critically ill patients, potentially reducing mortality and morbidity.
How similar studies have gone: While the incidence of rhythm disorders in other critical conditions is documented, this specific focus on VA ECMO patients is novel and has not been extensively studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient 18 years of age or older * Assistance with VA ECMO Exclusion Criteria: * Opposition to the use of data. * Persons under legal protection (curators, guardianship), judicially safeguarded. * VA ECMO for refractory cardiac arrest.
Where it's running
-
CHU Angers
Angers, France Recruiting -
Hospices Civils de Lyon - Hôpital Louis Pradel
Bron, France Recruiting -
CHU Caen Normandie - Hôpital Côte de Nacre
Caen, France Recruiting -
CHU Dijon Bourgogne - Hôpital François Mitterrand
Dijon, France Recruiting -
CHU Grenoble Alpes - Site Nord
Grenoble, France Recruiting -
CHU Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, France Recruiting
Show 14 more locations
-
CHU Nantes - Hôpital Nord Laennec
Nantes, France Recruiting -
Pitié Salpêtrière Hospital, Intensive Care Unit - Resuscitation
Paris, France Recruiting -
Pitié-Salpêtrière Hospital, Cardiovascular Surgery Intensive Care Unit
Paris, France Recruiting -
Hôpital Européen Georges Pompidou
Paris, France Recruiting -
Hôpital Bichat
Paris, France Recruiting -
Hôpital Bichat
Paris, France Recruiting -
CHU Rennes, Hôpital Pontchaillou
Rennes, France Recruiting -
CHU Toulouse - Hôpital de Rangueil
Toulouse, France Recruiting -
CHU Toulouse - Hôpital de Rangueil
Toulouse, France Recruiting -
CHRU Nancy - Hôpitaux de Brabois
Vandœuvre-lès-Nancy, France Recruiting -
CHRU Tours - Hôpital Trousseau
Chambray-lès-Tours, France Not yet recruiting -
CHU Lille - Institut Cœur Poumon
Lille, France Not yet recruiting -
CHU Bordeaux - Hôpital cardiologique, GH Sud Pessac
Pessac, France Not yet recruiting -
Hôpitaux universitaires de Strasbourg - Hôpital Civil
Strasbourg, France Completed
Study contacts
- Study coordinator: Adrien Bougle, PhD
- Email: Adrien.bougle@aphp.fr
- Phone: +33 1 42 16 29 91
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Leadless Conduction System Pacemaker for Chronic Bradycardia
This study tests a leadless AVEIR CSP pacemaker to see if it safely and reliably keeps heart rhythm in adults who need a pacemaker.
-
LivIQ leadless pacemaker system for ventricular pacing
This trial will test the LivIQ leadless pacemaker in adults who need ventricular pacing (VVI or VDD) to see if it is safe and maintains appropriate heart rhythm and AV timing.
-
Monitoring the safety of MicroPort CRM heart devices
This study is checking the long-term safety of MicroPort CRM heart devices to see how well they work and if there are any unexpected side effects for people who use them.
-
Registry for evaluating Medtronic products
This study is collecting information to see how safe and effective Medtronic products are for patients who are using them.
-
Sleep clinic outcomes and treatment practices at St. Olavs
This study will see how usual clinic care — cognitive behavioral therapy for insomnia (CBT‑I) and chronotherapy — works for adults referred to a sleep clinic with insomnia or circadian rhythm sleep problems.
-
Improving sleep and circadian alignment in critically ill patients in the ICU
This study tests a new approach to help critically ill patients in the ICU get better sleep and improve their body clocks by using strategies like light exposure and mobility.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.